Oral etoposide in the treatment of cutaneous large-cell lymphomas. A preliminary report of four cases.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1467294.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The favourable results of oral etoposide as single-agent therapy in four patients with a cutaneous lymphoma other than mycosis fungoides are reported. In all cases other chemotherapeutic options were limited because of prior chemotherapy or the age of the patients. Therapy with etoposide resulted in an initial complete remission in all patients, and was associated with minimal side-effects.
Medical subject headings
- Etoposide
- Lymphoma, Large B-Cell, Diffuse
- Skin Neoplasms